
Global Opioid Narcotics Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Opioid Narcotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Opioid Narcotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Narcotics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Opioid Narcotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Opioid Narcotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Opioid Narcotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Opioid Narcotics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Narcotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Narcotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Opioid Narcotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Opioid Narcotics sales, projected growth trends, production technology, application and end-user industry.
Opioid Narcotics Segment by Company
Yichang Renfu Pharmaceutical Co., Ltd.
Jiangsu Enhua Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Sinopharm Group Industrial Co., Ltd. Langfang Branch
Changzhou Siyao Pharmaceutical Co., Ltd.
Reig Jofre
Pfizer
GSK
Fresenius Kabi
Daiichi Sankyo
AcelRx Pharmaceuticals, Inc
Abbott
Opioid Narcotics Segment by Type
Fentanyl
Remifentanil
Sufentanil
Opioid Narcotics Segment by Application
Hospital
Clinic
Other
Opioid Narcotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Opioid Narcotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Narcotics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
195 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Opioid Narcotics Market by Type
- 1.2.1 Global Opioid Narcotics Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Fentanyl
- 1.2.3 Remifentanil
- 1.2.4 Sufentanil
- 1.3 Opioid Narcotics Market by Application
- 1.3.1 Global Opioid Narcotics Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Opioid Narcotics Market Dynamics
- 2.1 Opioid Narcotics Industry Trends
- 2.2 Opioid Narcotics Industry Drivers
- 2.3 Opioid Narcotics Industry Opportunities and Challenges
- 2.4 Opioid Narcotics Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Opioid Narcotics Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global Opioid Narcotics Revenue by Region
- 3.2.1 Global Opioid Narcotics Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Opioid Narcotics Revenue by Region (2020-2025)
- 3.2.3 Global Opioid Narcotics Revenue by Region (2026-2031)
- 3.2.4 Global Opioid Narcotics Revenue Market Share by Region (2020-2031)
- 3.3 Global Opioid Narcotics Sales Estimates and Forecasts 2020-2031
- 3.4 Global Opioid Narcotics Sales by Region
- 3.4.1 Global Opioid Narcotics Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global Opioid Narcotics Sales by Region (2020-2025)
- 3.4.3 Global Opioid Narcotics Sales by Region (2026-2031)
- 3.4.4 Global Opioid Narcotics Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Opioid Narcotics Revenue by Manufacturers
- 4.1.1 Global Opioid Narcotics Revenue by Manufacturers (2020-2025)
- 4.1.2 Global Opioid Narcotics Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global Opioid Narcotics Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Opioid Narcotics Sales by Manufacturers
- 4.2.1 Global Opioid Narcotics Sales by Manufacturers (2020-2025)
- 4.2.2 Global Opioid Narcotics Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global Opioid Narcotics Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global Opioid Narcotics Sales Price by Manufacturers (2020-2025)
- 4.4 Global Opioid Narcotics Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Opioid Narcotics Manufacturers, Product Type & Application
- 4.7 Global Opioid Narcotics Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Opioid Narcotics Market CR5 and HHI
- 4.8.2 2024 Opioid Narcotics Tier 1, Tier 2, and Tier 3
- 5 Opioid Narcotics Market by Type
- 5.1 Global Opioid Narcotics Revenue by Type
- 5.1.1 Global Opioid Narcotics Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global Opioid Narcotics Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global Opioid Narcotics Revenue Market Share by Type (2020-2031)
- 5.2 Global Opioid Narcotics Sales by Type
- 5.2.1 Global Opioid Narcotics Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global Opioid Narcotics Sales by Type (2020-2031) & (K Units)
- 5.2.3 Global Opioid Narcotics Sales Market Share by Type (2020-2031)
- 5.3 Global Opioid Narcotics Price by Type
- 6 Opioid Narcotics Market by Application
- 6.1 Global Opioid Narcotics Revenue by Application
- 6.1.1 Global Opioid Narcotics Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global Opioid Narcotics Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global Opioid Narcotics Revenue Market Share by Application (2020-2031)
- 6.2 Global Opioid Narcotics Sales by Application
- 6.2.1 Global Opioid Narcotics Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global Opioid Narcotics Sales by Application (2020-2031) & (K Units)
- 6.2.3 Global Opioid Narcotics Sales Market Share by Application (2020-2031)
- 6.3 Global Opioid Narcotics Price by Application
- 7 Company Profiles
- 7.1 Yichang Renfu Pharmaceutical Co., Ltd.
- 7.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Comapny Information
- 7.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
- 7.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 7.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
- 7.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
- 7.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Comapny Information
- 7.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
- 7.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 7.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
- 7.3 Henan Lingrui Pharmaceutical Co., Ltd.
- 7.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Comapny Information
- 7.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
- 7.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 7.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
- 7.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
- 7.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Comapny Information
- 7.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
- 7.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
- 7.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
- 7.5 Changzhou Siyao Pharmaceutical Co., Ltd.
- 7.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Comapny Information
- 7.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
- 7.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
- 7.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
- 7.6 Reig Jofre
- 7.6.1 Reig Jofre Comapny Information
- 7.6.2 Reig Jofre Business Overview
- 7.6.3 Reig Jofre Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Reig Jofre Opioid Narcotics Product Portfolio
- 7.6.5 Reig Jofre Recent Developments
- 7.7 Pfizer
- 7.7.1 Pfizer Comapny Information
- 7.7.2 Pfizer Business Overview
- 7.7.3 Pfizer Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Pfizer Opioid Narcotics Product Portfolio
- 7.7.5 Pfizer Recent Developments
- 7.8 GSK
- 7.8.1 GSK Comapny Information
- 7.8.2 GSK Business Overview
- 7.8.3 GSK Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 GSK Opioid Narcotics Product Portfolio
- 7.8.5 GSK Recent Developments
- 7.9 Fresenius Kabi
- 7.9.1 Fresenius Kabi Comapny Information
- 7.9.2 Fresenius Kabi Business Overview
- 7.9.3 Fresenius Kabi Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
- 7.9.5 Fresenius Kabi Recent Developments
- 7.10 Daiichi Sankyo
- 7.10.1 Daiichi Sankyo Comapny Information
- 7.10.2 Daiichi Sankyo Business Overview
- 7.10.3 Daiichi Sankyo Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
- 7.10.5 Daiichi Sankyo Recent Developments
- 7.11 AcelRx Pharmaceuticals, Inc
- 7.11.1 AcelRx Pharmaceuticals, Inc Comapny Information
- 7.11.2 AcelRx Pharmaceuticals, Inc Business Overview
- 7.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
- 7.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
- 7.12 Abbott
- 7.12.1 Abbott Comapny Information
- 7.12.2 Abbott Business Overview
- 7.12.3 Abbott Opioid Narcotics Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 Abbott Opioid Narcotics Product Portfolio
- 7.12.5 Abbott Recent Developments
- 8 North America
- 8.1 North America Opioid Narcotics Market Size by Type
- 8.1.1 North America Opioid Narcotics Revenue by Type (2020-2031)
- 8.1.2 North America Opioid Narcotics Sales by Type (2020-2031)
- 8.1.3 North America Opioid Narcotics Price by Type (2020-2031)
- 8.2 North America Opioid Narcotics Market Size by Application
- 8.2.1 North America Opioid Narcotics Revenue by Application (2020-2031)
- 8.2.2 North America Opioid Narcotics Sales by Application (2020-2031)
- 8.2.3 North America Opioid Narcotics Price by Application (2020-2031)
- 8.3 North America Opioid Narcotics Market Size by Country
- 8.3.1 North America Opioid Narcotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America Opioid Narcotics Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America Opioid Narcotics Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
- 9 Europe
- 9.1 Europe Opioid Narcotics Market Size by Type
- 9.1.1 Europe Opioid Narcotics Revenue by Type (2020-2031)
- 9.1.2 Europe Opioid Narcotics Sales by Type (2020-2031)
- 9.1.3 Europe Opioid Narcotics Price by Type (2020-2031)
- 9.2 Europe Opioid Narcotics Market Size by Application
- 9.2.1 Europe Opioid Narcotics Revenue by Application (2020-2031)
- 9.2.2 Europe Opioid Narcotics Sales by Application (2020-2031)
- 9.2.3 Europe Opioid Narcotics Price by Application (2020-2031)
- 9.3 Europe Opioid Narcotics Market Size by Country
- 9.3.1 Europe Opioid Narcotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe Opioid Narcotics Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe Opioid Narcotics Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
- 10 China
- 10.1 China Opioid Narcotics Market Size by Type
- 10.1.1 China Opioid Narcotics Revenue by Type (2020-2031)
- 10.1.2 China Opioid Narcotics Sales by Type (2020-2031)
- 10.1.3 China Opioid Narcotics Price by Type (2020-2031)
- 10.2 China Opioid Narcotics Market Size by Application
- 10.2.1 China Opioid Narcotics Revenue by Application (2020-2031)
- 10.2.2 China Opioid Narcotics Sales by Application (2020-2031)
- 10.2.3 China Opioid Narcotics Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Opioid Narcotics Market Size by Type
- 11.1.1 Asia Opioid Narcotics Revenue by Type (2020-2031)
- 11.1.2 Asia Opioid Narcotics Sales by Type (2020-2031)
- 11.1.3 Asia Opioid Narcotics Price by Type (2020-2031)
- 11.2 Asia Opioid Narcotics Market Size by Application
- 11.2.1 Asia Opioid Narcotics Revenue by Application (2020-2031)
- 11.2.2 Asia Opioid Narcotics Sales by Application (2020-2031)
- 11.2.3 Asia Opioid Narcotics Price by Application (2020-2031)
- 11.3 Asia Opioid Narcotics Market Size by Country
- 11.3.1 Asia Opioid Narcotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia Opioid Narcotics Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia Opioid Narcotics Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Opioid Narcotics Market Size by Type
- 12.1.1 SAMEA Opioid Narcotics Revenue by Type (2020-2031)
- 12.1.2 SAMEA Opioid Narcotics Sales by Type (2020-2031)
- 12.1.3 SAMEA Opioid Narcotics Price by Type (2020-2031)
- 12.2 SAMEA Opioid Narcotics Market Size by Application
- 12.2.1 SAMEA Opioid Narcotics Revenue by Application (2020-2031)
- 12.2.2 SAMEA Opioid Narcotics Sales by Application (2020-2031)
- 12.2.3 SAMEA Opioid Narcotics Price by Application (2020-2031)
- 12.3 SAMEA Opioid Narcotics Market Size by Country
- 12.3.1 SAMEA Opioid Narcotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA Opioid Narcotics Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA Opioid Narcotics Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 Opioid Narcotics Value Chain Analysis
- 13.1.1 Opioid Narcotics Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Opioid Narcotics Production Mode & Process
- 13.2 Opioid Narcotics Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Opioid Narcotics Distributors
- 13.2.3 Opioid Narcotics Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.